-
1
-
-
0028052932
-
Serum concentrations of clozapine and its major metabolites: Effects of co-treatment with fluoxetine or valproate
-
Centorrino F, Baldessarini RJ, Kando J, Frankenburg FR, Volpicelli SA, Puopolo PR, Flood JG (1994). Serum concentrations of clozapine and its major metabolites: effects of co-treatment with fluoxetine or valproate. Am J Psychiatry 151:123-125.
-
(1994)
Am J Psychiatry
, vol.151
, pp. 123-125
-
-
Centorrino, F.1
Baldessarini, R.J.2
Kando, J.3
Frankenburg, F.R.4
Volpicelli, S.A.5
Puopolo, P.R.6
Flood, J.G.7
-
2
-
-
0029953653
-
Serum levels of clozapine and norclozapine in patients treated with selective serotonin re-uptake inhibitors
-
Centorrino F, Baldessarini RJ, Frankenburg FR, Kando J, Volpicelli SA, Flood JG (1996). Serum levels of clozapine and norclozapine in patients treated with selective serotonin re-uptake inhibitors. Am J Psychiatry 153:820-822.
-
(1996)
Am J Psychiatry
, vol.153
, pp. 820-822
-
-
Centorrino, F.1
Baldessarini, R.J.2
Frankenburg, F.R.3
Kando, J.4
Volpicelli, S.A.5
Flood, J.G.6
-
3
-
-
0029950811
-
Elevated clozapine levels after fluvoxamine initiation
-
Dequardo JR, Roberts M (1996). Elevated clozapine levels after fluvoxamine initiation. Am J Psychiatry 153:840-841.
-
(1996)
Am J Psychiatry
, vol.153
, pp. 840-841
-
-
Dequardo, J.R.1
Roberts, M.2
-
5
-
-
0028874129
-
Measurement of clozapine and norclozapine in plasma/serum by high performance liquid chromatography and ultraviolet detection
-
McCarthy PT, Hughes S, Paton C (1995). Measurement of clozapine and norclozapine in plasma/serum by high performance liquid chromatography and ultraviolet detection. Biomed Chromatogr 9:36-41.
-
(1995)
Biomed Chromatogr
, vol.9
, pp. 36-41
-
-
McCarthy, P.T.1
Hughes, S.2
Paton, C.3
-
6
-
-
0028944753
-
Metabolism and bioactivation of clozapine by human liver in vitro
-
Pirmohamed M, Williams D, Madden S, Templeton E, Park BK (1995). Metabolism and bioactivation of clozapine by human liver in vitro. J Pharmacol Exp Ther 272:984-990.
-
(1995)
J Pharmacol Exp Ther
, vol.272
, pp. 984-990
-
-
Pirmohamed, M.1
Williams, D.2
Madden, S.3
Templeton, E.4
Park, B.K.5
-
7
-
-
0029553002
-
Selective serotonin reuptake inhibitors and tricyclic antidepressants in combination - Interactions and therapeutic uses
-
Taylor D (1995). Selective serotonin reuptake inhibitors and tricyclic antidepressants in combination - interactions and therapeutic uses Br J Psychiatry 167:575-580.
-
(1995)
Br J Psychiatry
, vol.167
, pp. 575-580
-
-
Taylor, D.1
-
8
-
-
0029522448
-
The use of clozapine plasma levels in optimising therapy
-
Taylor D, Duncan D (1995). The use of clozapine plasma levels in optimising therapy. Psychiatr Bull 19:753-55.
-
(1995)
Psychiatr Bull
, vol.19
, pp. 753-755
-
-
Taylor, D.1
Duncan, D.2
-
9
-
-
0029906284
-
Editorial - Cytochromes and psychotropic drug interactions
-
Taylor D, Lader M (1996). Editorial - cytochromes and psychotropic drug interactions. Br J Psychiatry 168:529-532.
-
(1996)
Br J Psychiatry
, vol.168
, pp. 529-532
-
-
Taylor, D.1
Lader, M.2
-
10
-
-
0029133057
-
Clozapine interaction. Increased plasma concentrations with concomitant risperidone: Case report
-
Tyson SC, Devane CL, Risch SC (1995). Clozapine interaction. Increased plasma concentrations with concomitant risperidone: case report. Am J Psychiatry 152:1401-1402.
-
(1995)
Am J Psychiatry
, vol.152
, pp. 1401-1402
-
-
Tyson, S.C.1
Devane, C.L.2
Risch, S.C.3
|